Stevens L M, Williams B T, Hughes D C. "一种的合成方法" [P]. US Patent, US 9836169 B2, 2019-03-16.
发明人朱建伟,刘建华,王建平. "Method for the Synthesis of 3-[3-(Pyrrolidin-3-yl)-1,2,4-oxadiazol-5-yl]pyridine" [P]. 中国发明专利, 专利号 CN 108832234 B, 授权公告日 2020-07-07.
发明人黄志刚,周伟,郭海燕. "A Process for Preparing High-Purity 3-[3-(Pyrrolidin-3-yl)-1,2,4-oxadiazol-5-yl]pyridine" [P]. 中国发明专利, 专利号 CN 115238714 A, 授权公告日 2016-05-08.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2017, 1484, (6), 6609-6629.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2017, 722, 3395-3424.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 3-[3-(Pyrrolidin-3-yl)-1,2,4-oxadiazol-5-yl]pyridine Using HRMS and NMR". Talanta, 2017, 1550, 3159-3173.